BSX250110P79000
- 0.00
- 0.000.00%
Boston Scientific Newsroom
Bernstein Adjusts Price Target on Boston Scientific to $110 From $100, Keeps Outperform Rating
Are Boston Scientific Corporation (NYSE:BSX) Investors Paying Above The Intrinsic Value?
Boston Scientific to Acquire Remaining Ownership Stake in Bolt Medical for $664m
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Biomea Fusion (BMEA) and Solid Biosciences (SLDB)
Here's Why Boston Scientific Corp. (BSX) Skyrocketed Today
Boston Scientific Bolt Medical Acquisition 'Checks Right Boxes,' JPMorgan Says
Top Gap Ups and Downs on Wednesday: EBAY, SOUN, STLA and More
Strategic Acquisition of Bolt Medical Positions Boston Scientific for Long-Term Growth in Interventional Cardiology
Fed Meeting Minutes Leave Equities Mixed
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
J&J Pause 'Very Good' for Boston Scientific, Says Piper Sandler
Boston Scientific Acquiring Bolt Medical in $443 Million Deal
Equities Largely Unchanged After Labor Market Data, Fed Governor Remarks
Johnson & Johnson Falls After Pausing Varipulse Cases
Express News | CNBC Halftime Report Final Trades: Apollo Global Management, UnitedHealth Group, IShares U.S. Financial ETF, Boston Scientific
Needham Maintains Boston Scientific(BSX.US) With Hold Rating
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
U.S. stocks movement | Agreement reached to acquire Bolt Medical, Boston Scientific (BSX.US) rises nearly 5%.
On Wednesday, Boston Scientific (BSX.US) rose by nearly 5%, reaching a new historical high of $96.42.
AAR Posts Upbeat Results, Joins AngioDynamics, EBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
BTIG Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $101